Skip to main content
Erschienen in: Supportive Care in Cancer 12/2021

23.06.2021 | COVID-19 | Original Article Zur Zeit gratis

Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic

verfasst von: Nienke Zomerdijk, Michelle Jongenelis, Camille E. Short, Andrew Smith, Jane Turner, Kathryn Huntley

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

The COVID-19 pandemic has had a disruptive effect on people with haematological cancers, who represent a high-risk population due to the nature of their disease and immunosuppressive treatments. We aimed to identify the psychological impacts of the COVID-19 pandemic on haematology patients and identify correlated factors to inform the development of appropriate supportive interventions.

Methods

Three hundred and ninety-four respondents volunteered their participation in response to a study advertisement distributed online through established haematology groups. Participants completed a self-report online survey exploring wellbeing, psychological distress, unmet supportive care needs, and fear of cancer recurrence.

Results

At least 1 in 3 respondents (35%) reported clinical levels of distress and nearly 1 in 3 (32%) identified at least one unmet need. Among respondents in remission (n = 134), clinical fear of cancer recurrence was reported by nearly all (95%). Unmet needs, pre-existing health conditions, younger age, financial concerns, and perceived risk of contracting COVID-19 were the dominant factors contributing to psychological distress during the pandemic. Psychological distress, lost income, perceived inadequate support from care team, perceived risk of contracting COVID-19, and being a woman were significantly associated with unmet needs. Psychological distress and concern about the impact of COVID-19 on cancer management were significantly associated with fear of cancer recurrence among respondents in remission.

Conclusion

Results highlight the high psychological burden and unmet needs experienced by people with haematological cancers during the COVID-19 pandemic and indicate a need for innovative solutions to rapidly identify distress and unmet needs during, and beyond, pandemic times.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu C-Y, Desai A, de Lima Lopes D Jr (2020) Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395(10241):1907–1918CrossRef Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu C-Y, Desai A, de Lima Lopes D Jr (2020) Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395(10241):1907–1918CrossRef
10.
Zurück zum Zitat Edge R, Mazariego C, Li Z, Canfell K, Miller A, Koczwara B, Shaw J, Taylor N (2021) Psychosocial impact of COVID-19 on cancer patients, survivors, and carers in Australia: a real-time assessment of cancer support services. Support Care Cancer:1-11. https://doi.org/10.1007/s00520-021-06101-3 Edge R, Mazariego C, Li Z, Canfell K, Miller A, Koczwara B, Shaw J, Taylor N (2021) Psychosocial impact of COVID-19 on cancer patients, survivors, and carers in Australia: a real-time assessment of cancer support services. Support Care Cancer:1-11. https://​doi.​org/​10.​1007/​s00520-021-06101-3
11.
Zurück zum Zitat Leach CR, Kirkland EG, Masters M, Sloan K, Rees-Punia E, Patel AV, Watson L (2021) Cancer survivor worries about treatment disruption and detrimental health outcomes due to the COVID-19 pandemic. J Psychosoc Oncol:1–16 Leach CR, Kirkland EG, Masters M, Sloan K, Rees-Punia E, Patel AV, Watson L (2021) Cancer survivor worries about treatment disruption and detrimental health outcomes due to the COVID-19 pandemic. J Psychosoc Oncol:1–16
13.
17.
Zurück zum Zitat Mengling T, Rall G, Bernas SN, Astreou N, Bochert S, Boelk T, Buk D, Burkard K, Endert D, Gnant K, Hildebrand S, Köksaldi H, Petit I, Sauter J, Seitz S, Stolze J, Weber K, Weber M, Lange V, Pingel J, Platz A, Schäfer T, Schetelig J, Wienand E, Geist S, Neujahr E, Schmidt AH (2020) Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS. Bone Marrow Transplant. https://doi.org/10.1038/s41409-020-01138-0CrossRefPubMedPubMedCentral Mengling T, Rall G, Bernas SN, Astreou N, Bochert S, Boelk T, Buk D, Burkard K, Endert D, Gnant K, Hildebrand S, Köksaldi H, Petit I, Sauter J, Seitz S, Stolze J, Weber K, Weber M, Lange V, Pingel J, Platz A, Schäfer T, Schetelig J, Wienand E, Geist S, Neujahr E, Schmidt AH (2020) Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS. Bone Marrow Transplant. https://​doi.​org/​10.​1038/​s41409-020-01138-0CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Australian Bureau of Statistics (2016) Australian Standard Geographical Classification (ASGC) Volume 5 Remoteness Structure. ABS. http://www.abs.gov.au. Accessed 4 September 2020 Australian Bureau of Statistics (2016) Australian Standard Geographical Classification (ASGC) Volume 5 Remoteness Structure. ABS. http://​www.​abs.​gov.​au. Accessed 4 September 2020
27.
Zurück zum Zitat Thewes B, Butow P, Bell ML, Beith J, Stuart-Harris R, Grossi M, Capp A, Dalley D, Committee FSA (2012) Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer 20(11):2651–2659. https://doi.org/10.1007/s00520-011-1371-xCrossRefPubMed Thewes B, Butow P, Bell ML, Beith J, Stuart-Harris R, Grossi M, Capp A, Dalley D, Committee FSA (2012) Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer 20(11):2651–2659. https://​doi.​org/​10.​1007/​s00520-011-1371-xCrossRefPubMed
29.
33.
Zurück zum Zitat Hamilton JG, Wu LM, Austin JE, Valdimarsdottir H, Basmajian K, Vu A, Rowley SD, Isola L, Redd WH, Rini C (2013) Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation. Psycho-Oncol 22(4):911–921. https://doi.org/10.1002/pon.3091CrossRef Hamilton JG, Wu LM, Austin JE, Valdimarsdottir H, Basmajian K, Vu A, Rowley SD, Isola L, Redd WH, Rini C (2013) Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation. Psycho-Oncol 22(4):911–921. https://​doi.​org/​10.​1002/​pon.​3091CrossRef
Metadaten
Titel
Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic
verfasst von
Nienke Zomerdijk
Michelle Jongenelis
Camille E. Short
Andrew Smith
Jane Turner
Kathryn Huntley
Publikationsdatum
23.06.2021
Verlag
Springer Berlin Heidelberg
Schlagwort
COVID-19
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2021
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06369-5

Weitere Artikel der Ausgabe 12/2021

Supportive Care in Cancer 12/2021 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.